The Amyloidosis Research Consortium Inc (EIN: 47-2589708) is a nonprofit organization dedicated to accelerating the development of advanced diagnostic tools and effective treatments for systemic amyloidosis through collaboration and innovation. With an operating budget of $3 million and total revenue of $3.4 million for the 2024 filing year, the organization is supported by multiple significant funders, none of which contribute 50% or more of its revenue. More information can be found on their website at www.arci.org.